Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Life Sciences

full industries list
Life Sciences Image
News
Events
Litigation Blog
Hatch-Waxman

Fish  attorneys have served as leading advisors to pioneers in the pharmaceutical, biotechnology, and life sciences fields for more than a century. For three consecutive years, we have been named the top US law firm for life sciences and biotechnology IP work by Managing Intellectual Property magazine. Clients choose Fish because of the technical and scientific expertise of our internationally recognized attorneys.

Large and small companies, along with academic and research institutions, turn to Fish’s team to protect their most valuable innovations. We offer biotechnology and pharmaceutical clients services that include:

  • Patent portfolio planning, strategic advice, opinions, and prosecution
  • Post-grant proceedings at the USPTO
  • Litigation services, including representation in Hatch-Waxman cases
  • FDA expertise
  • Counsel on licensing and other transactions

We have a rapidly expanding practice representing branded pharmaceutical companies in Hatch-Waxman litigation. Biotechnology and pharmaceutical companies trust Fish’s litigation team to handle these complicated, high-stakes cases because we are the world’s most experienced patent litigators.

Examples of our biotechnology and pharmaceutical work include:

  • Representing dozens of biotechnology and pharmaceutical clients in patent infringement litigation
  • Successfully litigating ANDA cases on behalf of branded pharmaceuticals
  • Obtaining patents for therapeutic agents and methods currently in clinical trials, including tumor-specific agents such as oncolytics viruses and humanized antibodies and methods for treating strokes
  • Patenting groundbreaking tissue engineering patents on breakthroughs that show promise in treating spinal cord injuries
  • Obtaining the first patent on a genetically engineered animal
  • Gaining FDA approvals for small molecule drugs and biologics, including gene and cell therapies, antibiotics, immunologics, and anti-anxiety medications
  • Conducting intellectual property due diligence on thousands of licensing agreements for the merger of two large pharmaceuticals companies in just a few months’ time

Notable Wins

Fish Wins Federal Circuit Affirmance of Reversal of $200 Million Damages Against Gilead

Fish won a unanimous Federal Circuit opinion today that affirmed its June 2016 post-trial wipe-out of a $200 million jury verdict against client Gilead Sciences, Inc. after proving Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of litigation and business misconduct constituting “unclean hands.”

Read more about this precedential opinion here and here.

Fish Wipes Out $2.5B Patent Verdict Against Gilead Sciences

Fish & Richardson won a motion for Judgment as a Matter of Law (JMOL) that reversed a $2.5 billion jury verdict against its client Gilead Sciences Inc. in federal court in Delaware.

Read about this historic win here and here.

Recent Webinars

2021

2020

2019

2018

Mayo/Myriad Tracker

Search Fish Team

Search by Letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
No matches
Life Sciences

Life Sciences Team

What's Trending in Life Sciences

Filter by
Event
February 23rd, 2021 | 8:00 am CET
C5 13th Annual Pharma & Biotech Patent Litigation in Europe
Speaking Engagement
Conference/Convention
News
January 26, 2021
Kurt Glitzenstein Quoted in The American Lawyer "Litigation Leaders" Article
Media Mention
News
News
January 7, 2021
Fish & Richardson Receives 2020 “Attorney of the Year” Group Award from Minnesota Lawyer
Press Release
Recognition
News
News
January 5, 2021
Fish & Richardson Elevates Its Most Diverse Principal Class Ever
Press Release
News
Event
January 28th, 2021 | 1:30 pm EST
Webinar | Biosimilars - 2020 Year in Review
Webinar
Event
January 27th, 2021 | 1:30 pm EST
Life Sciences Webinar Series | 2020 Year in Review
Webinar
Event
February 2nd, 2021 | 9:00 am GMT
LSX World Congress 2021
Speaking Engagement
Conference/Convention
Event
January 6th, 2021 | 4:00 pm GMT
One Nucleus: BioWednesday Webinar - How to Get the Most Out of a Virtual JP Morgan Week
Speaking Engagement
Event
December 10th, 2020 | 11:40 am PST
21st Annual Berkeley-Stanford Advanced Patent Law Institute (APLI)
Speaking Engagement
Conference/Convention
Event
December 3rd, 2020 | 10:30 am EST
Xconomy: Xcelerating Life Sciences - New York & Philadelphia
Speaking Engagement
Conference/Convention
Sponsorship
Event
December 5th, 2020 | 8:00 am EST
Chinese Antibody Society (CAS): Revisiting the Perspectives of Bispecific Antibodies under the COVID-19 Pandemic
Speaking Engagement
Sponsorship
Event
November 16th, 2020 | 3:00 am EST
Bio Integrates 2020
Speaking Engagement
Conference/Convention
load more topics